title: Activin betaA subunit, follistatin and follistatin-like 3 are expressed in the endometrium of ovariectomized rats and regulated by estrogen replacement.
abstract: Activin A is a growth factor expressed in the endometrium, where it modulates tissue remodeling and enhances decidualization. The effects of activin A are counteracted by two binding proteins, namely follistatin and follistatin-like 3 (FSTL3). We have evaluated the effects of estrogen and progestin on the endometrial expression of activin betaA subunit, follistatin and FSTL3 in ovariectomized rats. Adult female Wistar rats (n = 21) were ovariectomized and received one week later a single dose of estradiol benzoate (1.5 mg/kg body weight, i.m. injection), either alone (n = 7) or associated with depot medroxyprogesterone acetate (3 mg/kg body weight, i.m. injection, n = 7), or oil vehicle (control group, n = 7). One week later, activin betaA subunit mRNA levels had increased significantly in the uteri of rats treated with estradiol alone (7.4 fold increase over controls, P < 0.05) and to the same extent in rats receiving estradiol plus medroxyprogesterone (6.1 fold increase over controls, P < 0.05). This was accompanied by increase of betaA subunit immunostaining in estradiol and estroprogestin treated rats, which was noted only in the surface endometrial epithelium. Follistatin mRNA expression, conversely, showed a significant decrease in the groups treated with estrogen alone and estrogen plus progestin (P < 0.05), and follistatin immunostaining in the glandular epithelium was weaker in estradiol and estroprogestin-treated rats compared to controls. FSTL3 expression was similar in the 3 groups. In conclusion, the expression of activin betaA subunit increases and that of follistatin decreases following estrogen replacement in the endometrium of ovariectomized rats, and these effects are not further altered by the addition of progestin.
authors.affiliation: Department of Physiology, Federal University of Minas Gerais (UFMG), Belo Horizonte, MG, Brazil.
authors.forename: Márcia C
authors.initials: MC
authors.lastname: Ferreira
authors.forename: Inês K D
authors.initials: IK
authors.lastname: Cavallo
authors.forename: Pasquale
authors.initials: P
authors.lastname: Florio
authors.forename: Felice
authors.initials: F
authors.lastname: Petraglia
authors.forename: Fernando M
authors.initials: FM
authors.lastname: Reis
mesh_terms: D000818:Animals; D004717:Endometrium / Q000166:cytology / Q000378:metabolism*; D004967:Estrogens / Q000494:pharmacology*; D005260:Female; D038681:Follistatin / Q000096:biosynthesis*; D038702:Follistatin-Related Proteins / Q000096:biosynthesis*; D005786:Gene Expression Regulation / Q000187:drug effects*; D028322:Inhibin-beta Subunits / Q000096:biosynthesis*; D010052:Ovariectomy; D011372:Progestins / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar
chemical_list: D004967:Estrogens; D038681:Follistatin; D038702:Follistatin-Related Proteins; D011372:Progestins; C103008:inhibin beta A subunit; D028322:Inhibin-beta Subunits
references.citation: Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):11242-6
references.pmid: 8248234
references.citation: Reprod Sci. 2007 Jan;14(1):29-36
references.pmid: 17636213
references.citation: Int J Gynaecol Obstet. 2007 Oct;99(1):38-42
references.pmid: 17678930
references.citation: Reprod Biol Endocrinol. 2006 Sep 11;4:47
references.pmid: 16965620
references.citation: Nature. 1986 Jun 19-25;321(6072):776-9
references.pmid: 3012369
references.citation: Cell. 1991 Jun 14;65(6):973-82
references.pmid: 1646080
references.citation: Endocrinology. 2000 Sep;141(9):3510-3
references.pmid: 10965925
references.citation: J Clin Endocrinol Metab. 2002 Aug;87(8):4001-4
references.pmid: 12161551
references.citation: Biochimie. 1991 Jul-Aug;73(7-8):861-70
references.pmid: 1742361
references.citation: J Clin Endocrinol Metab. 2003 Sep;88(9):4432-9
references.pmid: 12970321
references.citation: J Soc Gynecol Investig. 2003 May;10(4):237-43
references.pmid: 12759153
references.citation: Aust N Z J Obstet Gynaecol. 2006 Jun;46(3):245-9
references.pmid: 16704482
references.citation: J Biol Chem. 1993 Sep 5;268(25):19013-8
references.pmid: 8395525
references.citation: Mol Hum Reprod. 2000 Dec;6(12):1107-17
references.pmid: 11101694
references.citation: Endocrinology. 1995 Sep;136(9):3815-22
references.pmid: 7544272
references.citation: Obstet Gynecol. 1998 May;91(5 Pt 1):685-92
references.pmid: 9572211
references.citation: Horm Metab Res. 1996 Apr;28(4):171-6
references.pmid: 8740191
references.citation: Mol Cell Endocrinol. 2004 Apr 15;218(1-2):129-35
references.pmid: 15130517
references.citation: Endocrinology. 2006 Feb;147(2):724-32
references.pmid: 16282351
references.citation: Hum Reprod. 1998 Dec;13(12):3469-77
references.pmid: 9886535
references.citation: Mol Cell Endocrinol. 2004 Oct 15;225(1-2):25-8
references.pmid: 15451564
references.citation: Methods. 2001 Dec;25(4):402-8
references.pmid: 11846609
references.citation: Science. 1992 Mar 27;255(5052):1702-5
references.pmid: 1313188
references.citation: Nature. 1986 Jun 19-25;321(6072):779-82
references.pmid: 3086749
references.citation: Histochem Cell Biol. 2004 Nov;122(5):461-71
references.pmid: 15480736
references.citation: Mol Cell Endocrinol. 2001 Jun 30;180(1-2):33-8
references.pmid: 11451569
references.citation: Eur J Endocrinol. 2004 Aug;151(2):251-7
references.pmid: 15296481
references.citation: Cytokine Growth Factor Rev. 2000 Mar-Jun;11(1-2):5-13
references.pmid: 10708948
references.citation: Mol Cell Endocrinol. 1996 Jan 15;116(1):105-14
references.pmid: 8822271